/Research Database
← Research Database
ModeratProspektivMensch2026

Association between the serum creatine kinase level and all-cause mortality in centenarians: a prospective cohort study in China.

Xinyan Gong, Xiaowei Cheng, Qingtao Zhang, Yue Niu et al.

Kernaussage

In community-dwelling centenarians, serum creatine kinase levels were independently and inversely associated with all-cause mortality in an inverse J-shaped manner.

Abstract

Muscle mass (MM) has a strong correlation with all-cause mortality. However, its assessment is not easily accessible and expensive. Serum creatine kinase (CK) has been proposed as a solution, but its association with mortality remains unclear. This study aimed to investigate the association between the serum CK level and all-causes mortality among centenarians in China. This prospective cohort study included Chinese centenarians residing in the community between June 2014 and December 2016. All-cause mortality was analyzed according to serum CK level using restricted cubic spline (RCS) analysis, Cox regression analysis, Kaplan-Meier curves, the log-rank test, and subgroup analysis. In total, 949 centenarians were eligible for participation and were followed up for a median of 29.4 months (IQR 14.5, 51.7). During the study period, 92.9% of the study participants died. RCS analysis revealed an inverse J-shaped relationship between the serum CK level and the risk of death. Mortality was 34.3% higher when the serum CK level was in the range of 8-66 U/L (Q1-Q2) than in the range of 66-192 U/L (Q3-Q4) (HR = 1.343 in multivariable analysis; 95%CI: 1.173-1.538; P<0.001). Kaplan-Meier analysis showed a significantly shorter median survival in the low-CK group (Q1-Q2) compared to the high-CK group (Q3-Q4). (26 months vs 36 months; P<0.001, log-rank test). Among community-dwelling centenarians, serum CK level was independently and inversely associated with all-cause mortality in an inverse J-shaped manner and may serve as a practical biomarker for physiological status and survival.

Kein medizinischer Rat. Die dargestellten Studien dienen der wissenschaftlichen Information und ersetzen keine ärztliche Beratung. Bei gesundheitlichen Fragen wende dich an eine approbierte Ärztin oder einen Arzt.

Quelle: PubMed Central / National Library of Medicine (NLM). Apollion steht in keiner Verbindung mit NLM und wird von NLM nicht empfohlen. Evidenzgrade bewerten die methodische Studienqualität — nicht die inhaltliche Richtigkeit.

Lizenz: CC BY — Inhalte werden ausschließlich aus Open-Access-Quellen mit kommerziell nutzbaren Lizenzen (CC0, CC BY, CC BY-SA) indexiert.